 Migraine Disorders
"Migraine Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Descriptor ID |
D008881
|
| MeSH Number(s) |
C10.228.140.546.399.750
|
| Concept/Terms |
Migraine Disorders- Migraine Disorders
- Disorder, Migraine
- Disorders, Migraine
- Migraine Disorder
- Migraine
- Migraines
- Migraine Headache
- Headache, Migraine
- Headaches, Migraine
- Migraine Headaches
Acute Confusional Migraine- Acute Confusional Migraine
- Acute Confusional Migraines
- Migraine, Acute Confusional
- Migraines, Acute Confusional
Hemicrania Migraine- Hemicrania Migraine
- Hemicrania Migraines
- Migraine, Hemicrania
- Migraines, Hemicrania
Migraine Variant- Migraine Variant
- Migraine Variants
- Variant, Migraine
- Variants, Migraine
Sick Headache- Sick Headache
- Headache, Sick
- Headaches, Sick
- Sick Headaches
Abdominal Migraine- Abdominal Migraine
- Abdominal Migraines
- Migraine, Abdominal
- Migraines, Abdominal
Cervical Migraine Syndrome- Cervical Migraine Syndrome
- Cervical Migraine Syndromes
- Migraine Syndrome, Cervical
- Migraine Syndromes, Cervical
|
Below are MeSH descriptors whose meaning is more general than "Migraine Disorders".
Below are MeSH descriptors whose meaning is more specific than "Migraine Disorders".
This graph shows the total number of publications written about "Migraine Disorders" by people in UAMS Profiles by year, and whether "Migraine Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2023 | 2 | 0 | 2 | | 2022 | 4 | 0 | 4 | | 2021 | 5 | 1 | 6 | | 2020 | 3 | 1 | 4 | | 2019 | 1 | 1 | 2 | | 2018 | 3 | 0 | 3 | | 2016 | 2 | 0 | 2 | | 2015 | 0 | 2 | 2 | | 2014 | 3 | 1 | 4 | | 2013 | 4 | 0 | 4 | | 2012 | 2 | 1 | 3 | | 2010 | 1 | 0 | 1 | | 2008 | 1 | 0 | 1 | | 2006 | 2 | 0 | 2 | | 2005 | 1 | 0 | 1 | | 2002 | 0 | 1 | 1 | | 1990 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Migraine Disorders" by people in Profiles over the past ten years.
-
Durfee KJ, Elbin RJ, Trbovich AM, Womble MN, Mucha A, Stephenson K, Holland CL, Dollar CM, Sparto PJ, Collins MW, Kontos AP. A Common Data Element-Based Adjudication Process for mTBI Clinical Profiles: A Targeted Multidomain Clinical Trial Preliminary Study. Mil Med. 2023 11 08; 188(Suppl 6):354-362.
-
Stephenson K, Womble MN, Frascoia C, Eagle SR, Covassin T, Kontos AP, Collins MW, Elbin RJ. Sex Differences on the Concussion Clinical Profiles Screening in Adolescents With Sport-Related Concussion. J Athl Train. 2023 Jan 01; 58(1):65-70.
-
Ailani J, Andrews JS, Tockhorn-Heidenreich A, Wenzel R, Rettiganti M. Effect of Galcanezumab on Total Pain Burden in Patients Who Had Previously Not Benefited from Migraine Preventive Medication (CONQUER Trial): A Post?Hoc Analysis. Adv Ther. 2022 Oct; 39(10):4544-4555.
-
Ambrosini A, Estemalik E, Pascual J, Rettiganti M, Stroud C, Day K, Ford J. Changes in acute headache medication use and health care resource utilization: Results from a randomized, double-blind, placebo-controlled clinical trial evaluating galcanezumab in adults with treatment-resistant migraine (CONQUER). J Manag Care Spec Pharm. 2022 Jun; 28(6):645-656.
-
Eagle SR, Kissinger-Knox AM, Feder A, Manderino L, Preszler J, Womble MN, Elbin RJ, Collins M, Kontos AP. Temporal Differences in Concussion Symptom Factors in Adolescents following Sports-Related Concussion. J Pediatr. 2022 06; 245:89-94.
-
Ailani J, Kuruppu DK, Rettiganti M, Oakes T, Schroeder K, Wietecha L, Port M, Blumenfeld AM. Does "wearing off" of efficacy occur in galcanezumab-treated patients at the end of the monthly treatment cycle? Post hoc analyses of four phase III randomized trials. Headache. 2022 02; 62(2):198-207.
-
Watkins JW, Lewis ZB. Diagnoses of Exclusion in the Workup of Abdominal Complaints. Emerg Med Clin North Am. 2021 Nov; 39(4):851-863.
-
Jedynak J, Eross E, Gendolla A, Rettiganti M, Stauffer VL. Shift from high-frequency to low-frequency episodic migraine in patients treated with Galcanezumab: results from two global randomized clinical trials. J Headache Pain. 2021 May 28; 22(1):48.
-
Pozo-Rosich P, Samaan KH, Schwedt TJ, Nicholson RA, Rettiganti M, Pearlman EM. Galcanezumab Provides Consistent Efficacy Throughout the Dosing Interval Among Patients with Episodic and Chronic Migraine: A Post Hoc Analysis. Adv Ther. 2021 06; 38(6):3154-3165.
-
Ahmed Z, Sommer RJ. Reassessing the PFO-Migraine Trials: Are We Closer to Closure? J Am Coll Cardiol. 2021 02 16; 77(6):677-679.
-
Stauffer VL, Oakes TM, Rettiganti M, Day KA, Camporeale A. Efficacy and safety of galcanezumab for preventive treatment of migraine: a systematic review and meta-analysis. J Neurol. 2021 May; 268(5):1980.
-
Ament M, Day K, Stauffer VL, Skljarevski V, Rettiganti M, Pearlman E, Aurora SK. Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine. J Headache Pain. 2021 Feb 06; 22(1):6.
-
Ford JH, Kurth T, Starling AJ, Ayer DW, Wietecha LA, Port MD, Rettiganti M, Ruff DD. Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine. Headache. 2020 Nov; 60(10):2304-2319.
-
Ailani J, Andrews JS, Rettiganti M, Nicholson RA. Impact of galcanezumab on total pain burden: findings from phase 3 randomized, double-blind, placebo-controlled studies in patients with episodic or chronic migraine (EVOLVE-1, EVOLVE-2, and REGAIN trials). J Headache Pain. 2020 Oct 17; 21(1):123.
-
Theroux LM, Cappa R, Mendoza A, Mallawaarachchi I, Samanta D, Goodkin HP. Implementation of an Intravenous Dihydroergotamine Protocol for Refractory Migraine in Children. Headache. 2020 Sep; 60(8):1653-1663.
-
Cohen PE, Sufrinko A, Elbin RJ, Collins MW, Sinnott AM, Kontos AP. Do Initial Symptom Factor Scores Predict Subsequent Impairment Following Concussion? Clin J Sport Med. 2020 03; 30 Suppl 1:S61-S68.
-
Ali MM, Tehrani AB, Mutter R, Henke RM, Cutler E, Pines JM, Mazer-Amirshahi M. Factors associated with potentially problematic opioid prescriptions among individuals with private insurance and medicaid. Addict Behav. 2019 11; 98:106016.
-
Luat AF, Juh?sz C, Loeb JA, Chugani HT, Falchek SJ, Jain B, Greene-Roethke C, Amlie-Lefond C, Ball KL, Davis A, Pinto A. Neurological Complications of Sturge-Weber Syndrome: Current Status and Unmet Needs. Pediatr Neurol. 2019 09; 98:31-38.
-
Sbeih F, Christov F, Gluth MB. Newly Diagnosed Meniere's Disease: Clinical Course With Initiation of Noninvasive Treatment Including an Accounting of Vestibular Migraine. Ann Otol Rhinol Laryngol. 2018 May; 127(5):331-337.
-
Adelborg K, Sz?pligeti SK, Holland-Bill L, Ehrenstein V, Horv?th-Puh? E, Henderson VW, S?rensen HT. Migraine and risk of cardiovascular diseases: Danish population based matched cohort study. BMJ. 2018 01 31; 360:k96.
-
Sufrinko A, McAllister-Deitrick J, Elbin RJ, Collins MW, Kontos AP. Family History of Migraine Associated With Posttraumatic Migraine Symptoms Following Sport-Related Concussion. J Head Trauma Rehabil. 2018 Jan/Feb; 33(1):7-14.
-
Kontos AP, Reches A, Elbin RJ, Dickman D, Laufer I, Geva AB, Shacham G, DeWolf R, Collins MW. Preliminary evidence of reduced brain network activation in patients with post-traumatic migraine following concussion. Brain Imaging Behav. 2016 06; 10(2):594-603.
-
Kontos AP, Sufrinko A, Elbin RJ, Puskar A, Collins MW. Reliability and Associated Risk Factors for Performance on the Vestibular/Ocular Motor Screening (VOMS) Tool in Healthy Collegiate Athletes. Am J Sports Med. 2016 Jun; 44(6):1400-6.
-
Lamvu G, Nguyen RH, Burrows LJ, Rapkin A, Witzeman K, Marvel RP, Hutchins D, Witkin SS, Veasley C, Fillingim R, Zolnoun D. The Evidence-based Vulvodynia Assessment Project. A National Registry for the Study of Vulvodynia. J Reprod Med. 2015 May-Jun; 60(5-6):223-35.
-
Chelimsky G, Kovacic K, Nugent M, Mueller A, Simpson P, Chelimsky TC. Comorbid Conditions Do Not Differ in Children and Young Adults with Functional Disorders with or without Postural Tachycardia Syndrome. J Pediatr. 2015 Jul; 167(1):120-4.
-
Samanta D. Transient lesion in the splenium of the corpus callosum in status migrainosus. Acta Neurol Belg. 2015 Sep; 115(3):397-8.
-
Deer TR, Mekhail N, Petersen E, Krames E, Staats P, Pope J, Saweris Y, Lad SP, Diwan S, Falowski S, Feler C, Slavin K, Narouze S, Merabet L, Buvanendran A, Fregni F, Wellington J, Levy RM. The appropriate use of neurostimulation: stimulation of the intracranial and extracranial space and head for chronic pain. Neuromodulation Appropriateness Consensus Committee. Neuromodulation. 2014 Aug; 17(6):551-70; discussion 570.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|